New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer
Can't see this email? View it online
   
  December 14, 2018  
  Respiratory Diseases  
  The latest respiratory diseases news from News Medical  
 New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancerNew nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer
 
Researchers have developed a new nuclear medicine tracer that could improve diagnosis and treatment of non-small cell lung cancer. Research published in the November issue of The Journal of Nuclear Medicine found that the new tracer, 99mTc-HYNIC-cMBP, produced clearer images in less time than currently used tracers and was more rapidly eliminated from the body, reducing radiation exposure.
 
   Nasal delivery of leptin hormone may help ease breathing problems during sleepNasal delivery of leptin hormone may help ease breathing problems during sleep
 
Experimenting with mice, Johns Hopkins Medicine researchers have added to evidence that a hormone best known for helping regulate hunger and body weight might also ease breathing problems experienced during sleep more effectively when given through the nose.
 
   New lung cancer guides aim to drive better outcomes and careNew lung cancer guides aim to drive better outcomes and care
 
Two new, national guides that aim to drive better outcomes and care for all people affected by lung cancer were released by Cancer Australia today. Lung cancer is the leading cause of death from cancer in Australia with an estimated 25 people dying every day from the disease in 2018.
 
 Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
 
Chronic rhinitis associated with hospital readmissions for asthma and COPD patientsPatients hospitalized for either asthma or chronic obstructive pulmonary disease have a higher risk of being readmitted for a hospital stay within 30 days of release if they also suffer from chronic rhinitis, according to a trio of researchers at the University of Cincinnati.
 
 
 Genetic study reveals new insights into underlying causes of moderate-to-severe asthma
 
Genetic study reveals new insights into underlying causes of moderate-to-severe asthmaThe largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.
 
 
 New project launched to map out lung cancer immunology
 
New project launched to map out lung cancer immunologyA 'rule book' to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announced today (Friday).
 
 
 Scientists identify mechanism used by lung cancer cells to obtain glucose
 
Scientists identify mechanism used by lung cancer cells to obtain glucoseScientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth.
 
 
 Study warns that potential epigenetic therapy may boost lung cancer stem cells
 
Study warns that potential epigenetic therapy may boost lung cancer stem cellsEpigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
 
 
 Governments across Europe respond in very different ways to lung cancer
 
Governments across Europe respond in very different ways to lung cancerThe World Health Organization estimates 387,913 Europeans will die of lung cancer in 2018. The preliminary findings from a new study by the Economist Intelligence Unit comparing 13 countries show that governments across Europe are responding in very different ways to the disease.